| abstract |
The present invention includes methods, compositions, cosmetic compositions and pharmaceutical compositions for enhancing degradation of nuclear receptor (NR) or STAT transcription factor proteins. The methods, compositions, cosmetics and pharmaceuticals of the present invention can be used to prevent or treat disorders or medical conditions that are at least partially affected by the nuclear receptor activation pathway or STAT activation pathway. |